Michael W. Freeman
Stock Analyst at Raymond James
(2.10)
# 3,231
Out of 4,592 analysts
45
Total ratings
35.5%
Success rate
1.6%
Average return
Main Sectors:
Stocks Rated by Michael W. Freeman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: PRN Profound Medical Corp. | Maintained: Buy | $15.42 | $10.38 | +48.57% | 5 | Jul 27, 2026 | |
| TSX: APTX Apotex Health Corp. | Initiated Coverage: Buy | $36.00 | $36.60 | -1.64% | 1 | Jul 6, 2026 | |
| TSX: AIDX Healwell AI Inc. | Maintained: Buy | $3.00 → $2.50 | $0.65 | +284.62% | 5 | Mar 25, 2026 | |
| TSX: HLS HLS Therapeutics Inc. | Maintained: Buy | $6.00 → $7.00 | $4.20 | +66.67% | 2 | Nov 18, 2025 | |
| TSX: WELL WELL Health Technologies Corp. | Maintained: Buy | n/a | $4.04 | - | 5 | Nov 6, 2025 | |
| TSX: MDP Medexus Pharmaceuticals Inc. | Maintained: Buy | $8.00 | $5.02 | +59.36% | 9 | Aug 14, 2025 | |
| TSX: VHI Vitalhub Corp. | Maintained: Buy | $14.50 → $15.00 | $6.84 | +119.30% | 6 | Aug 12, 2025 | |
| TSX: BHC Bausch Health Companies Inc. | Maintained: Hold | $11.22 | $9.65 | +16.22% | 7 | Aug 5, 2025 | |
| NGEN NervGen Pharma | Maintained: Buy | $3.21 → $4.28 | $1.62 | n/a | 3 | Jun 11, 2025 | |
| TSX: GUD Knight Therapeutics Inc. | Maintained: Buy | $8.00 | $9.84 | n/a | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1.50 | $0.30 | n/a | 1 | Nov 18, 2024 |
Profound Medical Corp.
Jul 27, 2026
Maintained: Buy
Price Target: $15.42
Current: $10.38
Upside: +48.57%
Apotex Health Corp.
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $36.00
Current: $36.60
Upside: -1.64%
Healwell AI Inc.
Mar 25, 2026
Maintained: Buy
Price Target: $3.00 → $2.50
Current: $0.65
Upside: +284.62%
HLS Therapeutics Inc.
Nov 18, 2025
Maintained: Buy
Price Target: $6.00 → $7.00
Current: $4.20
Upside: +66.67%
WELL Health Technologies Corp.
Nov 6, 2025
Maintained: Buy
Price Target: n/a
Current: $4.04
Upside: -
Medexus Pharmaceuticals Inc.
Aug 14, 2025
Maintained: Buy
Price Target: $8.00
Current: $5.02
Upside: +59.36%
Vitalhub Corp.
Aug 12, 2025
Maintained: Buy
Price Target: $14.50 → $15.00
Current: $6.84
Upside: +119.30%
Bausch Health Companies Inc.
Aug 5, 2025
Maintained: Hold
Price Target: $11.22
Current: $9.65
Upside: +16.22%
NervGen Pharma
Jun 11, 2025
Maintained: Buy
Price Target: $3.21 → $4.28
Current: $1.62
Upside: n/a
Knight Therapeutics Inc.
Mar 12, 2025
Maintained: Buy
Price Target: $8.00
Current: $9.84
Upside: n/a
Nov 18, 2024
Upgraded: Buy
Price Target: $1.50
Current: $0.30
Upside: n/a